Marc A. Pfeffer

基本信息

浏览量：1382

职业迁徙

个人简介

His clinical interests include cardiovascular disease, congestive heart failure, coronary artery disease and valvular heart disease. The author of over 450 peer-reviewed publications, he has received research funding from the American Heart Association and National Institutes of Health. Dr. Pfeffer has been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr. Pfeffer is the recipient of the Clinical Research Prize and the James Herrick Award, both from the American Heart Association.

研究兴趣

论文共 1238 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

RISK SCORE FOR FUTURE MYOCARDIAL INFARCTION AFTER AN ACUTE CORONARY SYNDROME AND PHARMACOGENETIC RESPONSE TO DALCETRAPIB

Jean Claude Tardif,Marc A. Pfeffer,Simon Kouz,Wolfgang Koenig, Aldo Pietro Maggioni,John J.V. McMurray, David D. Waters,Jean C. Gregoire,Philippe L. L’Allier, Johan Wouter Jukema,Harvey D. White,Therese Heinonen,David Kallend, Fouzia Laghrissi-Thode,Annik Fortier,Marie-Claude Guertin,Marie-Pierre Dube

Journal of the American College of Cardiologyno. 12 (2025): 1778

引用0浏览0引用

HEART RATE IN PATIENTS WITH ATRIAL FIBRILLATION/FLUTTER AND HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION: A PARTICIPANT-LEVEL ANALYSIS OF NEARLY 20,000 PATIENTS ACROSS 5 RANDOMIZED CLINICAL TRIALS

Alberto Foà, Henri Lu,Muthiah Vaduganathan,Hicham Skali,Brian Claggett,Akshay S. Desai,Pardeep S. Jhund,Marc A. Pfeffer,John J.V. McMurray, Scott Solomon

Journal of the American College of Cardiologyno. 12 (2025): 1229

引用0浏览0引用

INCREASED LIVER FIBROSIS RISK PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES AND MORTALITY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE PARAGON-HF TRIAL

ARZU KALAYCI, Sara Siqueira,Michael R. Zile,Marc A. Pfeffer,Carolyn S.P. Lam,Akshay S. Desai,Pardeep S. Jhund,Faiez Zannad,Brian Claggett,John J.V. McMurray, Scott Solomon,Muthiah Vaduganathan

Journal of the American College of Cardiology（2025）

引用0浏览0引用

Sudden Death in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Pooled Individual Patient-level Analysis of Five Randomized Clinical Trials

Robert W. Ariss,Brian L. Claggett,Muthiah Vaduganathan,Akshay S. Desai,Inder S. Anand,Michael R. Zile, Li Shen,Pardeep S. Jhund,Marc A. Pfeffer,John J.V. Mcmurray,Scott D. Solomon,Jonathan W. Cunningham

Journal of Cardiac Failureno. 1 (2025): 187

引用0浏览0引用

A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials

Henri Lu,Brian L. Claggett,Milton Packer,Maria A. Pabon,Marc A. Pfeffer,Eldrin F. Lewis,Carolyn S. P. Lam,Jean Rouleau,Michael R. Zile,Martin Lefkowitz,Akshay S. Desai,Pardeep S. Jhund,John J. V. Mcmurray,Scott D. Solomon,Muthiah Vaduganathan

JACC-HEART FAILUREno. 1 (2025): 58-71

引用0浏览0引用

NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial

Karola S Jering, Brian L Claggett,Eugene Braunwald, Christopher B Granger,Lars Køber,Ulf Landmesser, Eldrin F Lewis, Aldo P Maggioni, Douglas L Mann, John Jv McMurray,Roxana Mehran, Mark C Petrie, Margaret F Prescott, Jean L Rouleau,Morten Schou, Scott D Solomon, Philippe Gabriel Steg,Dirk VON Lewinski,Marc A Pfeffer

Journal of cardiac failure (2025)

引用0浏览0WOS引用

Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: the PARAGON-HF Trial